NASDAQ: CYTK
Cytokinetics Inc Stock Ownership - Who owns Cytokinetics?

Insider buying vs selling

Have Cytokinetics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Wendell WierengaDirector2025-10-274,375$10.00
$43.75kBuy
Wendell WierengaDirector2025-10-274,375$58.68
$256.73kSell
Fady Ibraham MalikEVP Research Development2025-10-212,105$58.22
$122.55kSell
Fady Ibraham MalikEVP Research Development2025-10-212,105$10.60
$22.31kBuy
Robert I. BlumPresident CEO2025-10-165,000$60.03
$300.15kSell
John T. HendersonDirector2025-10-15338$62.80
$21.23kBuy
Edward M. Md KayeDirector2025-10-15199$62.80
$12.50kBuy
Wendell WierengaDirector2025-10-1599$62.80
$6.22kBuy
Nancy WysenskiDirector2025-10-1599$62.80
$6.22kBuy
Robert Arthur HarringtonDirector2025-10-15199$62.80
$12.50kBuy

1 of 14

CYTK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CYTK insiders and whales buy or sell their stock.

CYTK Shareholders

What type of owners hold Cytokinetics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
T Rowe Price Investment Management Inc14.74%17,602,440$1.09BInstitution
Blackrock Inc13.13%15,677,867$971.56MInstitution
Vanguard Group Inc10.03%11,983,838$742.64MInstitution
Fmr LLC9.43%11,267,511$698.25MInstitution
Michael Schmertzler8.15%9,730,131$602.98MInsider
Wellington Management Group LLP6.55%7,827,679$485.08MInstitution
State Street Corp5.34%6,372,753$394.92MInstitution
Deep Track Capital LP3.06%3,650,000$226.19MInstitution
Ubs Group Ag2.57%3,070,665$190.29MInstitution
Geode Capital Management LLC2.51%2,994,445$185.57MInstitution

1 of 3

CYTK vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CYTK90.09%9.91%Net SellingNet Selling
NUVL75.12%24.88%Net SellingNet Selling
RYTM87.82%12.18%Net SellingNet Buying
CORT28.93%71.07%Net SellingNet Selling
HALO77.24%22.76%Net SellingNet Selling

Cytokinetics Stock Ownership FAQ

Who owns Cytokinetics?

Cytokinetics (NASDAQ: CYTK) is owned by 115.57% institutional shareholders, 12.72% Cytokinetics insiders, and 0.00% retail investors. Michael Schmertzler is the largest individual Cytokinetics shareholder, owning 9.73M shares representing 8.15% of the company. Michael Schmertzler's Cytokinetics shares are currently valued at $603.17M.

If you're new to stock investing, here's how to buy Cytokinetics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.